BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9662378)

  • 1. Cloning and functional analysis of human p51, which structurally and functionally resembles p53.
    Osada M; Ohba M; Kawahara C; Ishioka C; Kanamaru R; Katoh I; Ikawa Y; Nimura Y; Nakagawara A; Obinata M; Ikawa S
    Nat Med; 1998 Jul; 4(7):839-43. PubMed ID: 9662378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human p53-p51 (p53-related) fusion protein: a potent BAX transactivator.
    Ikawa S; Obinata M; Ikawa Y
    Jpn J Cancer Res; 1999 Jun; 90(6):596-9. PubMed ID: 10429649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
    Ishida S; Yamashita T; Nakaya U; Tokino T
    Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
    Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
    Senoo M; Matsumura Y; Habu S
    Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.
    Kojima T; Ikawa Y; Katoh I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
    Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
    Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of viral oncoproteins to target the p53-homologue p51A.
    Roth J; Dobbelstein M
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3251-3255. PubMed ID: 10567658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging p53 gene family.
    Kaelin WG
    J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family.
    Nozell S; Chen X
    Oncogene; 2002 Feb; 21(8):1285-94. PubMed ID: 11850848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer.
    Sasaki Y; Morimoto I; Ishida S; Yamashita T; Imai K; Tokino T
    Gene Ther; 2001 Sep; 8(18):1401-8. PubMed ID: 11571580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 family genes: structural comparison, expression and mutation.
    Ikawa S; Nakagawara A; Ikawa Y
    Cell Death Differ; 1999 Dec; 6(12):1154-61. PubMed ID: 10637430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and tissue distribution of novel KET/p63 splice variants.
    Bamberger C; Schmale H
    FEBS Lett; 2001 Jul; 501(2-3):121-6. PubMed ID: 11470269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
    Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
    Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
    Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
    Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation and expression of the p51 gene in human lung cancer.
    Tani M; Shimizu K; Kawahara C; Kohno T; Ishimoto O; Ikawa S; Yokota J
    Neoplasia; 1999 Apr; 1(1):71-9. PubMed ID: 10935472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new human p53 homologue.
    Trink B; Okami K; Wu L; Sriuranpong V; Jen J; Sidransky D
    Nat Med; 1998 Jul; 4(7):747-8. PubMed ID: 9662346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.